blue cross blue shield glp 1 of Michigan won't cover popular weight-loss drugs GLP-1 | Blue Cross and

Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

Clinical potential of treatment with semaglutide in type 2 diabetes patients

September 2025: First enforcement wave

Unrestricted coverage means patients can use their insurance right away to pay for GLP-1 drugs, GoodRx said, while restricted coverage requires meeting additional steps, including getting authorization from an insurer or first using a similar medication that is covered

In contrast, fructose, which crosses the cell membrane via glucose transporter 5 (GLUT5) [38], is not an effective stimulant of GIP secretion in either rodent models or healthy human subjects under normal condition [39]

This may be due to the medication directly, or as a result of other side effects like vomiting, which can lead to dehydration